Julien Vouillarmet

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.8K citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

FTO Is Increased in Muscle During Type 2 Diabetes, and Its Overexpression in Myotubes Alters Insulin Signaling, Enhances Lipogenesis and ROS Production, and Induces Mitochondrial Dysfunction

Amélie Bravard, Étienne Lefai, Emmanuelle Meugnier et al. · Diabetes · 2010 · 125 citations · Full text

Life Sciences, Molecular Biology, Physiology +16

Diabetes mellitus induced by PD-1 and PD-L1 inhibitors: description of pancreatic endocrine and exocrine phenotype

Lucien Marchand, Arnaud Thivolet, Stéphane Dalle et al. · Acta Diabetologica · 2018 · 95 citations

Medicine, Endocrinology, Pharmacology +15

Delayed referral of patients with diabetic foot ulcers across Europe: patterns between primary care and specialised units

Chris Manu, Elisabetta Lacopi, Benjamin Bouillet et al. · Journal of Wound Care · 2018 · 70 citations

Medicine, Family Medicine, Diabetic Foot Care +11

Activation of liver X receptors promotes lipid accumulation but does not alter insulin action in human skeletal muscle cells

D. Cozzone, Cyrille Debard, Nicolas Dif et al. · Diabetologia · 2006 · 58 citations · Full text

Life Sciences, Endocrinology, Physiology +17